[PDF] Top 20 FORMULATION AND DEVELOPMENT OF SUSTAINED RELEASE PELLETS OF GLIPIZIDE

... [2] Glipizide (BCS II) is an antidiabetic that used for the treatment of non insulin dependent diabetes mellitus ...[3] Glipizide is sparingly soluble in ethanol and acetone, and soluble in methylene ... See full document

... immediate release component using sodium starch glycolate and cross carmillose sodium as super disintegrates and Metformin hydrochloride (HCl) for sustained release by using hydroxyl propyl methyl ... See full document

... particular formulation in a specific condition, to remain within its physical, chemical, therapeutically and toxicological ...drug formulation which varies with time under the influence of various ... See full document

... Sustained release preparations are useful to reduce the dosage frequency to improve patient ...convenience. Sustained release pellets are easy to formulate by incorporating drug ... See full document

... result, pellets meant different things for different ...industry, pellets can be defined as small, free flowing,spherical particulates manufactured by the agglomeration of fine powders or granules of drug ... See full document

... Solubility study of Carvedilol solid dispersion The solubility studies of the solid dispersions from formulation A1 to A6 were carried out in distilled water. Accurately weighed amount of solid dispersion ... See full document

... A sustained drug delivery system that can be administered at night (before sleep) but that release drug in early morning would be a promising chronopharmaceutic system 4, 5 ... See full document

... controlled release of Glipizide over a period of 12 hours was obtained from matrix tablets (F1 to ...the formulation, F3 shows that 75.21% of drug release at the end of 12 ...plasma ... See full document

... Drug Release [11&12] : To study the mechanism of drug release from the matrix tablets, the drug release data were fitted to various kinetic models like zero order, first order, higuchi’s and ... See full document

... of sustained release microspheres having pH sensitivity property and microspheres were prepared by solvent-evaporation method using different drug polymer ratios (1:1 to1:3), stirring speeds (500-1000rpm), ... See full document

... controlled release drug delivery systems provide a therapeutic release of drug to the proper site in the body to achieve and maintain the desired drug ... See full document

... the development of solid dosage ...and pellets were prepared by applying 10 metric ton of pressure in hydraulic ...The pellets were then scanned over range of 4000-400cm ... See full document

... to release the active drug immediately after oral administration, to obtain rapid and complete systemic drug ...and development of new drug ...product. Sustained release dosage forms are ... See full document

... this formulation was mainly performed to analyse the changes of drug release ...the release rate of the drug from the microcapsule [24-26] ... See full document

... the development of sustained-release (SR) forms extremely advantageous, lornoxicam is weak acid having pKa ...action. Formulation of sustained release tablet is effective ... See full document

... drug-loaded sustained release glibenclamide pellets A uniform dry powder mixture (batch size 100 g) containing glibenclamide, MCC ( Avicel PH 101 ), locust bean gum, and gum ghatti/ guar gum is taken ... See full document

... modified release multiple dosage form with different release patterns such as immediate and sustained release pattern, taste masking of the drugs, gastro retentive floating and ...of ... See full document

... for pellets showing similar endothermic peak corresponding to melting point of pure drug, counteracting the results obtained from ...80% pellets were fall between size ranges of 420-1000µ Table ...90% ... See full document

... SRM pellets sample were studied for In vitro drug release studies using USP type I dissolution test apparatus (TDT-08L, Electrolab, India) with speed of 75 RPM at 37°C± ...SRM pellets equivalent to ... See full document

... drug release, stability of the matrix, safety profile, and release of molecules from the matrix, biocompatibility and biodegradability of the matrix ...of release of the active ingredient, in order ... See full document